Thrombohemorrhagic complications of myeloproliferative disorders.
Myeloproliferative disorders are commonly associated with thrombohemorrhagic manifestations. The current review highlights recent advances in understanding the epidemiology and pathogenetic mechanisms of thrombotic and bleeding complications. Therapeutic modalities and prophylactic interventions corresponding to the specific disease states are also discussed.
Papadakis
Emmanouil
E
Department of Hematology, Pappagergiou Hospital, Thessaloniki, Greece.
Hoffman
Ron
R
Brenner
Benjamin
B
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D009196:Myeloproliferative Disorders / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology; D013927:Thrombosis / Q000150:complications* / Q000188:drug therapy / Q000453:epidemiology
D000970:Antineoplastic Agents